Zoltán Kaló, Zsolt Abonyi-Tóth, György Rokszin, Tamás Agh, András Inotai
Impact of multiple switching on health care costs and outcomes in generic drug policies: the Hungarian case of losartan.
2017-07-07
Impact of multiple switching on health care costs and outcomes in generic drug policies: the Hungarian case of losartan.
Impact of multiple switching on health care costs and outcomes in generic drug policies: the Hungarian case of losartan.
340.78 kB |
21 grudnia 2017